急性髓性白血病的演变范式:针对不同年龄和风险群体的个性化治疗方法
Sumeet K Yadav1, Utsav Joshi2, Guleid Hussein1
1Hospital Internal Medicine, Mayo Clinic Health System, Mankato, MN 56001, USA.
Cancers
|September 13, 2025
概括
急性髓性白血病 (AML) 治疗正在转向个性化医疗. 现在的疗法针对特定的突变和患者的风险群体,以改善AML的结果.
科学领域:
- 血液瘤学 血液瘤学
- 分子诊断学 分子诊断
- 个性化医疗是个性化的医疗.
背景情况:
- 急性髓性白血病 (AML) 是一种侵袭性的血液癌症.
- 治疗历史上依赖于密集化疗.
- 分子诊断的进步使得风险分层和向治疗成为可能.
研究的目的:
- 审查AML当前的治疗范式.
- 突出个性化医疗在AML治疗中的作用.
- 讨论复发性/耐药性AML的新兴疗法.
主要方法:
- 审查当前的AML治疗策略.
- 强调分子诊断和风险分层.
- 讨论传统和新型治疗剂.
主要成果:
- 强化化疗 (例如",7 + 3") 是年轻,健康的患者的标准,通常使用向药物 (FLT3,IDH抑制剂).
- 低强度治疗 (低甲基化剂+静脉) 是老年/不适合患者的标准.
- 脂质体化疗 (CPX-351),MRD监测和维持疗法完善了缓解后的护理.
结论:
- 甲ML治疗正在转向个性化,基因突变驱动的策略.
- 新兴的疗法 (美因抑制剂,ADC,CAR-T,疫苗) 为复发性/耐药性AML提供了新的选择.
- 个性化医疗是改善AML患者在不同群体的治疗结果的关键.
关键词:
在CPX-351中使用.FLT3 抑制剂的使用.IDH 抑制剂的使用.门抑制剂是什么意思急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.可测量的残留疾病.分子造型分析 (MOP) 是一种分子造型分析.更多相关视频
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.8K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
30.4K
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Bone Marrow Sampling and Transplants
910
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
